Lip GY - Search Results

1

Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.

Kooiman J, van Rein N, Spaans B, van Beers KA, Bank JR, van de Peppel WR, del Sol AI, Cannegieter SC, Rabelink TJ, Lip GY, Klok FA, Huisman MV. Kooiman J, et al. Among authors: lip gy. PLoS One. 2014 May 9;9(5):e94420. doi: 10.1371/journal.pone.0094420. eCollection 2014. PLoS One. 2014. PMID: 24817475 Free PMC article.

2

Antiarrhythmics in atrial fibrillation.

Freestone B, Lip GY. Freestone B, et al. Among authors: lip gy. Curr Opin Investig Drugs. 2002 Jan;3(1):84-8. Curr Opin Investig Drugs. 2002. PMID: 12054078 Review.

3

Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?

Chung NA, Belgore F, Li-Saw-Hee FL, Conway DS, Blann AD, Lip GY. Chung NA, et al. Among authors: lip gy. Stroke. 2002 Sep;33(9):2187-91. doi: 10.1161/01.str.0000023889.84649.3d. Stroke. 2002. PMID: 12215585 Clinical Trial.

4

Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.

Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Conway DS, et al. Among authors: lip gy. Circulation. 2002 Oct 8;106(15):1962-7. doi: 10.1161/01.cir.0000033220.97592.9a. Circulation. 2002. PMID: 12370220 Clinical Trial.

5

Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly.

Kamath S, Lip GY. Kamath S, et al. Among authors: lip gy. Am J Geriatr Cardiol. 2002 Nov-Dec;11(6):357-62; quiz 363-4. doi: 10.1111/j.1076-7460.2002.00070.x. Am J Geriatr Cardiol. 2002. PMID: 12417841 Review.

6

A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.

Kamath S, Blann AD, Chin BS, Lanza F, Aleil B, Cazenave JP, Lip GY. Kamath S, et al. Among authors: lip gy. Eur Heart J. 2002 Nov;23(22):1788-95. doi: 10.1053/euhj.2002.3259. Eur Heart J. 2002. PMID: 12419299

7

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.

Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Conway DS, et al. Among authors: lip gy. Circulation. 2003 Jul 1;107(25):3141-5. doi: 10.1161/01.CIR.0000077912.12202.FC. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796127 Clinical Trial.

8

Fibrinolytic function and atrial fibrillation.

Marín F, Roldán V, Lip GY. Marín F, et al. Among authors: lip gy. Thromb Res. 2003 Mar 15;109(5-6):233-40. doi: 10.1016/s0049-3848(03)00259-7. Thromb Res. 2003. PMID: 12818244 Review.

9

Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.

Roldán V, Marín F, Blann AD, García A, Marco P, Sogorb F, Lip GY. Roldán V, et al. Among authors: lip gy. Eur Heart J. 2003 Jul;24(14):1373-80. doi: 10.1016/s0195-668x(03)00239-2. Eur Heart J. 2003. PMID: 12871695

10

Atrial fibrillation: should we target platelets or the coagulation pathway?

Tan KT, Lip GY. Tan KT, et al. Among authors: lip gy. Card Electrophysiol Rev. 2003 Dec;7(4):370-1. doi: 10.1023/B:CEPR.0000023141.17553.f1. Card Electrophysiol Rev. 2003. PMID: 15071256 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,945 results

Search Page